New Immune-Boosting drug targets Hard-to-Treat cancers

NCT ID NCT05365581

First seen Oct 01, 2025 · Last updated May 13, 2026 · Updated 29 times

Summary

This early-phase study tests a new drug, ASP2138, that helps the immune system find and attack cancer cells that have a specific marker called CLDN18.2. The study includes adults with advanced stomach, gastroesophageal junction, or pancreatic cancer that cannot be removed by surgery or has spread. ASP2138 is given alone or with standard treatments to find the safest dose and check for side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aichi Cancer Center

    RECRUITING

    Nagoya, Aichi-ken, Japan

  • Columbia University

    RECRUITING

    New York, New York, 10032, United States

  • Duke Children's Hospital and Health Center

    RECRUITING

    Durham, North Carolina, 27710, United States

  • Froedtert Hospital and the Medical College of Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

  • Henan Cancer Hospital

    RECRUITING

    Zhengzhou, Henan, China

  • Kanagawa Cancer Center

    RECRUITING

    Yokohama, Kanagawa, Japan

  • Kindai University Hospital

    RECRUITING

    Sakai, Osaka, Japan

  • Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 10065, United States

  • NYU Langone Medical Center - NYU Medical Oncology Associates

    RECRUITING

    New York, New York, 10016, United States

  • National Cancer Center Hospital

    RECRUITING

    Chuo-ku, Tokyo, Japan

  • National Cancer Center Hospital East

    RECRUITING

    Kashiwa, Chiba, Japan

  • Northwestern University

    RECRUITING

    Chicago, Illinois, 60611, United States

  • PanOncology Trials

    RECRUITING

    San Juan, Puerto Rico

  • Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

    RECRUITING

    Shanghai, Shanghai Municipality, China

  • Rutgers Cancer Institute of New Jersey

    COMPLETED

    New Brunswick, New Jersey, 08901, United States

  • Site ES34001

    RECRUITING

    Barcelona, Spain

  • Site ES34002

    RECRUITING

    Barcelona, Spain

  • Site ES34004

    RECRUITING

    Zaragoza, Spain

  • Site ES34006

    RECRUITING

    Barcelona, Spain

  • Site ES34007

    RECRUITING

    El Palmar, Spain

  • Site FR33001

    RECRUITING

    Saint-Herblain, France

  • Site FR33002

    RECRUITING

    Toulouse, France

  • Site FR33003

    RECRUITING

    Lyon, France

  • Site FR33004

    RECRUITING

    Marseille, France

  • Site FR33005

    RECRUITING

    Vaillant, Villejuif, France

  • Site FR33006

    RECRUITING

    Poitiers, France

  • Site IT39001

    RECRUITING

    Milan, Italy

  • Site IT39003

    RECRUITING

    Verona, Italy

  • Site IT39004

    RECRUITING

    Milan, Italy

  • Site IT39005

    RECRUITING

    Rozzano, Italy

  • Site KR82001

    RECRUITING

    Guro-gu, Seoul, South Korea

  • Site KR82002

    RECRUITING

    Jongno-gu, Seoul, South Korea

  • Site KR82003

    RECRUITING

    Seocho-gu, Seoul, South Korea

  • Site KR82004

    RECRUITING

    Seongnam-si, Gyeonggi-do, South Korea

  • Site KR82005

    RECRUITING

    Seodaemun-gu, Seoul, South Korea

  • Sun Yat-sen University Cancer Center

    RECRUITING

    Guangzhou, Guangdong, China

  • The Cancer Institute Hospital of Japanese Foundation for Cancer Research

    RECRUITING

    Koto-ku, Tokyo, Japan

  • The First Affiliated Hospital, College of Medicine, Zhejiang University

    RECRUITING

    Hangzhou, Zhejiang, China

  • The University of Osaka Hospital

    RECRUITING

    Suita, Osaka, Japan

  • UCLA Dept of Medicine - Hematology/Oncology, Santa Monica

    WITHDRAWN

    Santa Monica, California, 90404, United States

  • UT Southwestern Medical Center

    RECRUITING

    Dallas, Texas, 75390, United States

  • Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology

    RECRUITING

    Wuhan, Hubei, China

  • University of California Irvine Medical Center

    RECRUITING

    Orange, California, 92868, United States

  • University of Kansas Cancer Center

    RECRUITING

    Westwood, Kansas, 66205, United States

  • Virginia Mason Medical Center

    RECRUITING

    Seattle, Washington, 98101, United States

  • Wake Forest University Baptist Health

    RECRUITING

    Winston-Salem, North Carolina, 27103, United States

Conditions

Explore the condition pages connected to this study.